A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer-Reference-Cited by-同舟云学术

A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer

Published:2016-07-19 Issue:37 Volume:7 Page:59471-59481
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Han Donghui¹,Wu Jieheng²,Han Yueheng³,Wei Ming⁴,Han Sen⁵,Lin Ruihe³,Sun Ziyong⁶,Yang Fa¹,Jiao Dian⁴,Xie Pin¹,Zhang Lingling²,Yang An-Gang²,Zhao Aizhi³,Wen Weihong²,Qin Weijun¹

Affiliation:

1. Department of Urology, Xijing Hospital, Fourth Military Medical University, 710032 Xi'an, China

2. State Key Laboratory of Cancer Biology, Department of Immunology, Fourth Military Medical University, 710032 Xi'an, China

3. Department of Research & Development, OriMAbs Ltd. Science Center, Philadelphia, PA, 19104, USA

4. Department of Urology, Tangdu Hospital, Fourth Military Medical University, 710038 Xi'an, China

5. Department of Research & Development, Hangzhou Immusource Biotechnology Company, Ltd., Hangzhou, 310010, China

6. Institute of Molecular Medicine, Nanjing University, Nanjing, 210093, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically Engineered Membrane‐Coated Nanoparticles for Enhanced Prostate‐Specific Membrane Antigen Targeting and Ferroptosis Treatment of Castration‐Resistant Prostate Cancer;Advanced Science;2024-07

2. Adding value to banana farming: Antibody production in post-harvest leaves;Journal of Biotechnology;2024-05

3. Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection;Theranostics;2024

4. Future in precise surgery: Fluorescence-guided surgery using EVs derived fluorescence contrast agent;Journal of Controlled Release;2023-01

5. Genetically engineered macrophage membrane-coated nanoparticles for enhanced tumor targeting and synergistic cancer therapy;2022-09-23